IVI and Sweden
IVI Member State
On 2 April 1997 Ambassador Peter Osvald, Permanent representative of Sweden to United Nations in New York, signed the IVI Establishment Agreement. On that same day, the government of Sweden ratified the Agreement.
The government of Sweden is represented on the IVI Board of Trustees by Dr. Catharina Maijgren Steffensson, Associate Director and Medical Director of Nordics Sarepta Therapeutics.
Dr. Ros-Mari Bålöw, 2017-2018
Dr. Viveka Persson, 2011-2016
Prof. Ann-Mari Larsdotter Svennerholm, 2008 & 2010
Prof. Ragnar Norrby, 2004-2011, 2012
Prof. Jan Holmgren, 2001-2006
Since 2002, the Swedish International Development Cooperation Agency (Sida) has contributed annual program funding to IVI. Sida currently contributes approximately $1 million USD annually.
Cholera Vaccine Development
IVI’s Oral Cholera Vaccine originates from a formula developed at the University of Gothenburg.